Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

HEPARIN SODIUM 20,000 UNIT/ML VIAL

HEPARIN SODIUM
$7.6218per ML

Strength

20000 [USP'U]/mL

Manufacturer

Fresenius Kabi USA, LLC

NDC

63323091513

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAVENOUS; SUBCUTANEOUS

Last Updated

7/23/2025

Active Ingredients

HEPARIN SODIUM

Approval Type

New Drug (NDA)

FDA Application

NDA017029

On Market Since

2/22/1972

Pharmacological Classes

Anti-coagulant
Heparin
Unfractionated Heparin

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-6.7%

3Y

N/A

5Y

N/A

All

-9.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

SOD CITRATE-CITRIC ACID SOLN
Generic
00121059516•Pharmaceutical Associates, Inc.
$0.0249
per ML
SOD CITRATE-CITRIC ACID SOLN
Generic
62135043447•Chartwell RX LLC
$0.0249
per ML
TRICITRATES ORAL SOLUTION
Generic
00121067716•PAI Holdings LLC
$0.0351
per ML
TRICITRATES ORAL SOLUTION
Generic
62135043847•Chartwell RX LLC
$0.0351
per ML
POTASSIUM CIT-CITRIC ACID SOLN
Generic
00121067616•PAI Holdings LLC
$0.0496
per ML
POTASSIUM CIT-CITRIC ACID SOLN
Generic
62135043547•Chartwell RX LLC
$0.0496
per ML
ORACIT ORAL SOLUTION
Generic
46287001401•CMP Pharma, Inc.
$0.0722
per ML
EFFERVESCENT ANTACID-PAIN RLF
Generic
70000057401•Cardinal Health
$0.0846
per EA
POTASSIUM CITRATE ER 5 MEQ TAB
Generic
00245007011•Upsher-Smith Laboratories LLC
$0.1229
per EA
POTASSIUM CITRATE ER 5 MEQ TAB
Generic
00591268201•Actavis Pharma, Inc.
$0.1229
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy